We are live on ! Find out more
APC

Aspire Private Capital Portfolio holdings

AUM $484M
1-Year Est. Return 17.28%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+17.28%
3 Year Est. Return
+49.56%
5 Year Est. Return
+43.58%
10 Year Est. Return
AUM
$278M
AUM Growth
+$15.6M
Cap. Flow
+$69.4K
Cap. Flow %
0.02%
Top 10 Hldgs %
46.21%
Holding
696
New
20
Increased
144
Reduced
161
Closed
33
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FV icon
601
First Trust Dorsey Wright Focus 5 ETF
FV
$3.71B
$466 ﹤0.01%
10
DRLL icon
602
Strive US Energy ETF
DRLL
$286M
$442 ﹤0.01%
15
HYMC icon
603
Hycroft Mining Holding Corp
HYMC
$2.23B
$426 ﹤0.01%
80
STXS icon
604
Stereotaxis
STXS
$135M
$414 ﹤0.01%
200
BCML icon
605
BayCom
BCML
$334M
$380 ﹤0.01%
20
QTTB icon
606
Q32 Bio
QTTB
$482M
$378 ﹤0.01%
17
CPRX
607
DELISTED
Catalyst Pharmaceutical
CPRX
$372 ﹤0.01%
20
DRUG
608
Bright Minds Biosciences
DRUG
$796M
$370 ﹤0.01%
100
DKS icon
609
Dick's Sporting Goods
DKS
$18B
$361 ﹤0.01%
3
YOLO icon
610
AdvisorShares Pure Cannabis ETF
YOLO
$29.9M
$360 ﹤0.01%
100
ASIX icon
611
AdvanSix
ASIX
$543M
$347 ﹤0.01%
9
LAZR
612
DELISTED
Luminar Technologies
LAZR
$344 ﹤0.01%
5
AVX
613
Avax One Technology Ltd
AVX
$24M
0
DNOW icon
614
DNOW Inc
DNOW
$2.85B
$318 ﹤0.01%
25
IVVD icon
615
Invivyd
IVVD
$194M
$300 ﹤0.01%
200
ADNT icon
616
Adient
ADNT
$1.5B
$278 ﹤0.01%
8
FATH
617
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$264 ﹤0.01%
10
GMDA
618
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$258 ﹤0.01%
200
ONL
619
Orion Office REIT
ONL
$149M
$256 ﹤0.01%
30
GSK icon
620
GSK
GSK
$105B
$246 ﹤0.01%
7
CTXR icon
621
Citius Pharmaceuticals
CTXR
$18.2M
$237 ﹤0.01%
12
NTZ
622
Natuzzi
NTZ
$14.8M
$231 ﹤0.01%
30
BTTX
623
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$221 ﹤0.01%
200
TLRY icon
624
Tilray
TLRY
$617M
$188 ﹤0.01%
7
ON icon
625
ON Semiconductor
ON
$18.8B
$187 ﹤0.01%
3
-3
-50% -$200

Similar funds

Aspire Private Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Aspire Private Capital held 696 positions worth $278M, up 5.9% from $263M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Aspire Private Capital's Q4 2022 filing shows 20 new, 144 increased, 161 reduced and 33 closed positions. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 6,632 shares worth $271K. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $6.89M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4% a quarter earlier, followed by Industrials and Healthcare.

  • Aspire Private Capital's largest Q4 2022 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 6,632 shares worth $271K.
  • Aspire Private Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $5.82M increase.
  • Aspire Private Capital's biggest Q4 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $6.89M.
  • Aspire Private Capital fully exited Invesco Water Resources ETF in Q4 2022, selling an estimated $59K.
  • Aspire Private Capital's ten largest holdings make up 46% of its $278M portfolio in Q4 2022.
  • Aspire Private Capital opened 20 new positions and closed 33 in Q4 2022.
  • Aspire Private Capital's portfolio value rose 5.9% quarter-over-quarter to $278M.

Based on Aspire Private Capital's 13F filing for Q4 2022, filed 14 Feb 2023.